Taiping Zhang

ORCID: 0000-0003-1689-6908
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Neuroendocrine Tumor Research Advances
  • Pancreatitis Pathology and Treatment
  • Alkaline Phosphatase Research Studies
  • Bone health and treatments
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • MicroRNA in disease regulation
  • Renal cell carcinoma treatment
  • Metalloenzymes and iron-sulfur proteins
  • RNA modifications and cancer
  • Cancer Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Peptidase Inhibition and Analysis
  • ATP Synthase and ATPases Research
  • Neuroblastoma Research and Treatments
  • Click Chemistry and Applications
  • Gallbladder and Bile Duct Disorders
  • Lung Cancer Research Studies
  • Ferroptosis and cancer prognosis
  • Circular RNAs in diseases
  • Cancer Diagnosis and Treatment
  • Cancer Cells and Metastasis

Peking Union Medical College Hospital
2015-2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2015-2024

Shandong Geological Sciences Institute
2024

Academy of Medical Sciences
2014-2023

Nanjing Medical University
2022

Jiangsu Province Hospital
2022

Fudan University Shanghai Cancer Center
2021

Imperial College London
2020

Tsinghua University
2020

Christie's
2016

DNA modifications such as 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are epigenetic marks known to affect global gene expression in mammals. Given their prevalence the human genome, close correlation with high chemical stability, these could serve ideal biomarkers for cancer diagnosis. Taking advantage of a highly sensitive selective labeling technology, we report here genome-wide profiling 5hmC circulating cell-free (cfDNA) genomic (gDNA) paired tumor adjacent tissues...

10.1038/cr.2017.121 article EN cc-by Cell Research 2017-09-19

Chemoresistance is one of the main causes poor prognosis in pancreatic cancer patients. Understanding mechanisms implicated chemoresistance critical to improving patient outcomes. Recent evidences indicate that long noncoding RNAs (lncRNAs) are involving cancer. However, lncRNAs contribute resistance and remain largely unknown. The objective this study construct a chemoresistance-related lncRNA-associated competing endogenous RNA (ceRNA) network identify key regulating network.Firstly,...

10.1186/s13045-019-0777-7 article EN cc-by Journal of Hematology & Oncology 2019-09-12

Background: Pancreatic cancer is highly lethal and aggressive with increasing trend of mortality in both genders. An effective prediction model needed to assess prognosis patients for optimization treatment. Materials methods: Seven datasets mRNA expression clinical data were obtained from gene omnibus (GEO) database. Level 3 clinicopathological The Cancer Genome Atlas pancreatic ductal adenocarcinoma (TCGA‑PAAD) dataset. Differentially expressed genes (DEGs) between tumor normal tissue...

10.3389/fonc.2019.00996 article EN cc-by Frontiers in Oncology 2019-09-27

Self-complementary adeno-associated virus (scAAV) vectors can significantly minimize the vector load required to achieve sustained transgene expression. In this study, transcriptional regulatory elements were systematically screened produce constitutive and liver-specific scAAV factor IX (FIX) expression cassettes. addition, optimization of GC content, cis- elements, codon usage in human FIX (hFIX) increased 4–20-fold. A was developed that capable expressing high levels comparison with...

10.1038/sj.mt.6300355 article EN cc-by-nc-nd Molecular Therapy 2007-12-04

Objectives The aim of this study was to determine the etiology tendency acute pancreatitis (AP) in Beijing region and relationship with influencing factors. Methods This retrospective multicenter enrolled 8 representative general hospitals from January 1, 2006 December 31, 2010. analyzed, defined sex, aging, severity, mortality, recrudesce rate, length stay, hospitalization cost. Results 2461 patients. total number increasing year by year. Causes included biliary (1372, 55.75%), alcoholism...

10.1097/mpa.0000000000000273 article EN Pancreas 2014-11-27

Reprogrammed energy metabolism has become an emerging hallmark of cancer in recent years. Transporters have been reported to be amino acid sensors involved controlling mTOR recruitment and activation, which is crucial for the growth both normal tumor cells. L-type transporter 2 (LAT2), encoded by SLC7A8 gene, a Na+-independent neutral responsible transporting acids, including glutamine, can activate mTOR. Previous studies shown that LAT2 was overexpressed gemcitabine-resistant pancreatic...

10.1186/s13046-018-0947-4 article EN cc-by Journal of Experimental & Clinical Cancer Research 2018-11-12

Insulinomas and non-functional pancreatic neuroendocrine tumours (NF-PanNETs) have distinctive clinical presentations but share similar pathological features. Their genetic bases not been comprehensively compared. Herein, we used whole-genome/whole-exome sequencing (WGS/WES) to identify differences between insulinomas NF-PanNETs.The mutational profiles copy-number variation (CNV) patterns of 211 PanNETs, including 84 127 NF-PanNETs, were obtained from WGS/WES data provided by Peking Union...

10.1136/gutjnl-2018-317233 article EN cc-by-nc Gut 2019-08-28

Abstract Purpose: Gemcitabine is most commonly used for pancreatic cancer. However, the molecular features and mechanisms of frequently occurring resistance remain unclear. This work aims at exploring gemcitabine identifying candidate biomarkers combinatorial targets treatment. Experimental Design: In this study, we established 66 patient-derived xenografts (PDXs) on basis clinical cancer specimens treated them with gemcitabine. We generated multiomics data (including whole-exome sequencing,...

10.1158/1078-0432.ccr-19-3975 article EN Clinical Cancer Research 2021-03-05

Chemoresistance is one of the causes poor prognosis in pancreatic cancer patients. However, mechanisms resistance remain unclear. Here we screened miRNAs associated with drug cancer, and identified a panel dysregulated gemcitabine-resistance cells, including 13 downregulated 20 upregulated miRNAs. Further studies focusing on miR-497 demonstrated that suppressed cells proliferation, decreased percentage S phase re-sensitized to gemcitabine erlotinib, attenuated migration invasion capacities....

10.18632/oncotarget.2184 article EN Oncotarget 2014-07-08

Objectives: To identify plasma microRNA (miRNA) markers of pancreatic cancer (PC). Background: Accurate pretreatment diagnosis PC remains challenging, whether miRNAs could be used as biomarkers in unknown. Methods: In this multiphase multicenter study, peripheral blood samples were obtained preoperatively 3 phases: the discovery phase [7 patients with PC, 6 chronic pancreatitis (CP), and 5 healthy volunteers (N)], preliminary validation (29 16 CP, 31 N), large sample (156 65 N, 57 27...

10.1097/sla.0000000000001345 article EN Annals of Surgery 2015-06-26

Abstract Background By regulating target genes, microRNAs play essential roles in carcinogenesis and drug resistance human pancreatic ductal adenocarcinoma (PDAC). Previous studies have shown that microRNA-10a-5p (miR-10a-5p) is overexpressed PDAC acts as an oncogene to promote the metastatic behavior of cells. However, role miR-10a-5p chemoresistance remains unclear. Methods The effects on biological behaviors were analyzed. MiR-10a-5p TFAP2C levels tissues detected, clinical value was...

10.1186/s13046-018-0739-x article EN cc-by Journal of Experimental & Clinical Cancer Research 2018-04-03
Coming Soon ...